Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma

MacKie, R. and Bray, C.A. (2004) Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. British Journal of Cancer, 90(4), pp. 770-772. (doi: 10.1038/sj.bjc.6601595)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1038/sj.bjc.6601595

Abstract

A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kelly, Mrs Caroline and MacKie, Prof Rona
Authors: MacKie, R., and Bray, C.A.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:British Journal of Cancer
Journal Abbr.:BJC
ISSN:0007-0920
ISSN (Online):1532-1827

University Staff: Request a correction | Enlighten Editors: Update this record